CUTASEPT
CUTASEPT
CUTASEPT
Cutasept G
Skin antiseptics for use before injections, punctures and
surgical procedures with fast and comprehensive activity.
Skin Antisepsis
Cutasept F
Directions for use
Cutasept F is an uncoloured, propanolbased skin antiseptic having a rapid and
broad effect. The ready-to-use preparation is
used for the preoperative skin antisepsis as
well as before blood samplings and
injections.
Product properties
acts rapidly and comprehensively
good sustained effect
excellent skin compatibility
good adhesion of incision foils
Composition
Active ingredients in 100 g:
Propan-2-ol 63.0 g (equals 72 vol. %),
Benzalkonium Chloride 0.025 g.
Other ingredients: Purified Water.
Microbiology
bactericidal
yeasticidal
tuberculocidal
virucidal against enveloped viruses
Areas of application
Cutasept F is recommended for the following
application areas:
skin antisepsis prior to injections,
Proven efficacy
Exposure time/
Procedure
Skin antisepsis
Before injections and
punctures
15 s
Before punctures of
joints,visceral cavities,
hollow organs,and surgical
procedures.
1 min
2 min
Bacteria
Bactericidal acc. to DGHM
(P. aeruginosa, S.aureus,
E.hirae, E.coli, P. mirabilis)
15 s
MRSA/ EHEC
1 min
Mycobacteria
Tuberculocidal (M. terrae)
30 s
Fungi
Yeasticidal (C. albicans)
15 s
Viruses
Enveloped viruses
Virucidal against
enveloped viruses
(incl. HCV, HIV, HBV)
30 s
Nonenveloped viruses
Rotavirus
30 s
Note
consult a doctor prior to use in
neonates and infants
not suitable for the disinfection of
large, open wounds and mucous
membranes
do not use on skin beneath
tourniquet cuffs
avoid pooling
avoid contact with eyes
Chemical-physical data
Appearance
Density (20 C)
pH value 50 % (v/v)
Flash point
(acc. to DIN 51755)
uncoloured
solution
approx.
3
0.87 g/cm
approx. 8.5
21 C
Stability
after opening:
12 months
Cutasept G
Directions for use
Cutasept G is a coloured, propanol-based
skin antiseptic for the preoperative skin
antisepsis that marks the disinfected skin
area. In addition, the ready-to-use
preparation is used prior to injections,
catheterisation, punctures, blood
sampling and small invasive procedures.
Cutasept G acts rapidly and
comprehensively, and possesses an
excellent sustained effect.
Product properties
acts rapidly and comprehensively
good sustained effect
coloured for marking the disinfection
area
excellent skin compatibility
good adhesion of incision foils
Composition
Active ingredients in 100 g:
Propan-2-ol 63.0 g (equals 72 vol. %),
Benzalkonium Chloride 0.025 g.
Other ingredients: Purified Water.
Dyes: Sunset Yellow S (E110), Quinoline
Yellow (E104), Brilliant Black (E151).
Microbiology
bactericidal
yeasticidal
tuberculocidal
virucidal against enveloped viruses
Areas of application
Cutasept G is recommended for the
following application areas:
skin antisepsis prior to injections,
punctures and surgical procedures in
hospitals, primary healthcare, in- and
outpatient geriatric care, and for home
dialysis
preoperative skin preparation with
marking of the disinfection area
postoperative treatment of skin sutures
and adjoining areas
Proven efficacy
Exposure time/
Procedure
Skin antisepsis
Before injections and
punctures
15 s
Before punctures of
joints,visceral cavities,
hollow organs,and surgical
procedures.
1 min
2 min
Bacteria
Bactericidal acc. to DGHM
(P. aeruginosa, S.aureus,
E.hirae, E.coli, P. mirabilis)
15 s
MRSA/ EHEC
1 min
Mycobacteria
Tuberculocidal (M. terrae)
30 s
Fungi
Yeasticidal (C. albicans)
15 s
Viruses
Enveloped viruses
Virucidal against
enveloped viruses
(incl. HCV, HIV, HBV)
30 s
Nonenveloped viruses
Rotavirus
30 s
Note
consult a doctor prior to use in neonates
and infants
not suitable for the disinfection of large,
open wounds and mucous membranes
do not use on skin beneath tourniquet
cuffs
avoid pooling
avoid contact with eyes
Chemical-physical data
Appearance
Density (20 C)
pH value 50 % (v/v)
Flash point
(acc. to DIN 51755)
reddish brown
solution
approx.
3
0.82 g/cm
approx. 8.2
21.5 C
Stability
after opening:
12 months
Sustained effect
Skin rich
in sebaceous
glads
Skin poor
in sebaceous
glands
Presentation Cutasept F
50 ml spray bottle,
250 ml spray bottle,
500 ml spray bottle,
1 litre bottle,
5 litre canister.
Presentation Cutasept G
50 ml spray bottle,
250 ml spray bottle,
500 ml spray bottle,
1 litre bottle,
5 litre canister.
Note: The recommendations regarding our preparations are based on scientific tests and are given in good faith. More detailed
recommendations, e.g. regarding material compatibility, are possible only in separate, individual cases. Our recommendations are
not binding and do not constitute a guarantee. They do not preclude a companys own testing for the intended purpose and
process. In this respect we cannot accept any liability. This is in accordance with our general conditions of sale and supply.
02/14
Thus, they retard the growth of the resident flora. Skin antiseptics
that have been proven to be effective in practical trials to determine
the sustained effect in accordance with the German Society for
Hygiene and Microbiology (DGHM) [1] possess sustained activity:
even after 24 hours, the initial reduction in resident microorganisms
is still almost the same [2, 3].
1 Desinfektionsmittel-Kommission der DGHM: Richtlinie fr die Prfung und Bewertung von
Hautdesinfektionsmitteln Stand 1.1.1991. Zbl Hyg 1991; 192: 99-103.
2 Heeg P. Wirksamkeit von Cutasept F gegen die residente Hautflora.Krankenhaushygieniker.
Tbingen, 09.08.1992.
3 Christiansen B. Begutachtung von Cutasept G (gefrbt) als Prparat
fr die Hautdesinfektion. Leiterin der zentralen Einrichtung
Medizinaluntersuchungsamt und Krankenhaushygiene
Universittsklinikum Schleswig-Holstein, Campus Kiel, 21.07.2004.
PAUL HARTMANN AG
89522 Heidenheim
Germany